Risk factor
Strong & resilient to price shocks
Profitability factor
Excellent dividends
About
Established in 1992 and headquartered in Xinyang, China, Henan Lingrui Pharmaceutical Co., Ltd. specializes in the production and distribution of pharmaceutical products throughout the Chinese market. The company offers a broad catalog of approximately 100 different medications, provided in ten distinct dosage formats such as adhesive plasters, tablets, capsules, granules, and tinctures. Prominent items in their product line include Tongluoqutong plasters, Peiyuantongnao capsules, Danlutongdu tablets, stomachache free tablets, and Shenqi Hypoglycemic capsules.
Company Valuation
Considering past and projected metrics, the stock is 'cheaper' than its peers. Specifically, the stock is 'cheap' on P/E, neutral on EV/EBITDA, underpriced on P/FCF.
Target Price
The average target price of 600285.SS is 26.2 and suggests 33.3% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to